ADHD drug shows promise in reducing methamphetamine dependence in Australia

A study in Australia has found that lisdexamfetamine, a medication for ADHD, may help reduce methamphetamine dependence. The trial involved 164 adults who reported frequent meth use. Participants taking lisdexamfetamine used meth 8.8 days less on average over 12 weeks compared to those on a placebo. They also reported significantly higher treatment effectiveness and satisfaction. Currently, there are no approved medications for methamphetamine dependence. Researchers suggest that experienced clinicians might consider prescribing lisdexamfetamine off-label, with careful monitoring.